跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIPIPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ARIPIPRAZOLE
Authorized
STANDARD
ARIPIPRAZOLE
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ce01fede46dea3d6
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
ce01fede46dea3d6
Drug Approval Canada Name
ARIPIPRAZOLE
Product Name
ARIPIPRAZOLE
Status
Marketed
Status Date
2019-07-09
Original Market Date
2019-07-09
Din
02488000
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX12 ARIPIPRAZOLE
Atc Name
n 05 ax 12
Aig Number
0152514001
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
ARIPIPRAZOLE
2 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ce01fede46dea3d6
Type
Standard
Back to Health Canada Approvals